DOACs in Patients With Giant Coronary Artery Aneurysms After Kawasaki Disease

Kirsten B Dummer; Koichi Miyata; Chisato Shimizu; Adriana H Tremoulet; Jill Gleason; John B Gordon; Jane C Burns

doi:10.1001/jamanetworkopen.2023.43801

DOACs in Patients With Giant Coronary Artery Aneurysms After Kawasaki Disease

JAMA Netw Open. 2023 Nov 1;6(11):e2343801. doi: 10.1001/jamanetworkopen.2023.43801.

Authors

Kirsten B Dummer¹, Koichi Miyata¹, Chisato Shimizu¹, Adriana H Tremoulet¹, Jill Gleason², John B Gordon², Jane C Burns¹

Affiliations

¹ Department of Pediatrics, University of California San Diego, Rady Children's Hospital, San Diego.
² San Diego Cardiac Center, San Diego, California.

No abstract available

Plain language summary

This case series examines outcomes among patients with giant coronary artery aneurysms after Kawasaki disease treated with direct oral anticoagulants (DOACs).

MeSH terms

Coronary Aneurysm* / diagnostic imaging
Coronary Aneurysm* / etiology
Coronary Vessels
Humans
Immunoglobulins, Intravenous
Mucocutaneous Lymph Node Syndrome* / complications
Patients

Substances

Immunoglobulins, Intravenous